Walgreens strikes $683 million opioid deal with Florida

  • Walgreens Boots Boots Alliance (NASDAQ:WBA) has agreed to pay $683 million to settle claims that the company contributed to the opioid crisis in the state by improperly dispensing millions of painkillers, as per state officials.
  • The deal includes a one-time payment of $63 million for attorney's fees and $620 million to be paid out to the state over 18 years.
  • 'I am glad that we have been able to end this monumental litigation and move past the courtroom," Florida Attorney General Ashley Moody said.
  • In a statement, Deerfield, Illinois-based Walgreens Boots (WBA) did not admit wrongdoing. 'As the largest pharmacy chain in the state, we remain focused on and committed to being part of the solution, and believe this resolution is in the best interest of all parties involved and the communities we serve across Florida," Chief Legal Officer Danielle Gray remarked.

    For this year Walgreens Boots Boots's revenue will be around 1.06 billion USD. This is according to the average of the analysts' estimates. This is hugely lower than 2022's revenue of 1.26 billion USD.

    Historical revenues and results Walgreens Boots Boots plus estimates 2023

    aandelenkoers

    Walgreens Boots Boots Ann Arbor ©

    Walgreens Boots
    Walgreens Boots


    The analysts expect for 2023 a net profit of 105 million USD. According to most of the analysts the company will have a profit per share for this book year of 3.03 USD. So the price/earnings-ratio equals 31.59.

    Analysts expect a dividend of 2.52 USD per share. Thus the dividend yield equals 2.63 percent. The average dividend yield of the financial companies equals an attractive 3.55 percent.

    Walgreens Boots Boots's market capitalization is based on the number of outstanding shares around 3.07 billion USD.

    On Friday the stock closed at 95.73 USD.

    Historical stock prices Walgreens Boots Boots

    stock price walgreensboots

    ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
    news@valuespectrum.com

    Copyright analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.

    • Other stock news
    Analysts expect over 2021 rising revenue Walgreens Boots
    Analysts foresee more revenue Walgreens Boots
    Analysts expect over 2020 rising revenue Walgreens Boots
    Walgreens among highest dividend stocks in America
    Analysts count on revenue increase Walgreens
    Analysts expect revenue increase Walgreen
    Analysts expect over 2018 rising revenue Walgreen
    Sector news
    Analysts count on sales decrease Deutsche Boerse
    Analysts expect revenue increase Hypoport
    Allianz this year on track for record sales
    Analysts count on sales decrease Adyen
    Analysts expect over 2023 rising revenue Euronext, quite high dividend
    Analysts estimate for 2023 decreasing sales Morgan Stanley, quite high dividend
    Goldman Sachs now in top highest dividend yields in America
    National news
    NXP reaps benefits from FRAMOS collaboration
    Tesla net onder de 500.000 cars per year
    Analysts expect over 2024 revenue decrease Caterpillar
    Analysts expect sales decline Biogen
    Analysts anticipate for 2024 on revenue increase Cognizant
    Analysts expect over 2024 growing sales Colgate-Palmolive
    Analysts expect over 2024 revenue expansion Patterson-UTI Energy, relatively high dividend
    Press news
    Test News
    Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 3rd Interim Report
    Regarding the resignation of the member of the Board of EPSO-G Tomas Daukantas
    Gavin DeGraw and More Deliver Hope for the Holidays in Hospitals with Musicians On Call
    SJW Group Announces CPUC Decision Approving San Jose Water’s General Rate Case
    Crazy Woman Creek Bancorp Reports Earnings for Fiscal Year 2024; Declares Annual Cash Dividend of $0.32 Per Share
    GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds
    Logoanalist
    Returns European stocks
    Crypto currencies information
    About us Network Partners
    Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2024 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo